cAMP-elevating drugs are thought to mediate their biological effects by activating the cAMP/cAMP-dependent protein kinase (PKA) cascade. However, this hypothesis is difficult to confirm due to a lack of selective inhibitors. Here, we have probed the role of PKA in mediating inhibitory effects of several cAMP-elevating drugs in BEAS-2B epithelial cells using an adenovirus vector encoding a PKA inhibitor protein (PKI␣) and have compared it to H-89, a commonly used small molecule PKA inhibitor. Initial studies established efficient gene transfer and confirmed functionality of PKI␣ 48 h after virus infection. All cAMP-elevating drugs tested promoted the phosphorylation of cAMP response element-binding protein (CREB), activated a cAMP response element (CRE)-driven luciferase reporter gene, and suppressed both granulocyte/ macrophage colony-stimulating factor (GM-CSF) generation and [ 3 H]arachidonic acid (AA) release in response to interleukin-1 and monocyte chemotactic protein (MCP)-1, respectively. These effects were abolished by PKI␣. In contrast, H-89 behaved unpredictably under the same conditions. Thus, although CREB phosphorylation evoked by a range of cAMP-elevating drugs was abolished by H-89, neither activation of the CRE-dependent luciferase reporter gene construct nor the inhibition of GM-CSF generation was inhibited. Paradoxically, H-89 antagonized MCP-1-induced [ 3 H]AA release and enhanced the inhibitory effect of submaximal concentrations of rolipram and 8-bromo-cAMP. We suggest that expression of PKI␣ in susceptible cells provides a simple and unambiguous way to assess the role of PKA in cAMP signaling and to probe the mechanism of action of other drugs and cAMP-dependent responses where the participation of PKA is equivocal. Furthermore, these data suggest that H-89 is not a selective inhibitor of PKA and should be avoided.Through highly coordinated changes in the rate of synthesis and degradation, cAMP mediates the effect of a large number of hormones, autacoids, and neurotransmitters. Current dogma holds that agonism of Gs-coupled receptors augments the basal activity of one or more isoforms of adenylyl cyclase. The cAMP signal then is propagated and amplified through the activation of PKA, ultimately to effect a change in cell function (see Beavo and Brunton, 2002). In the inactive state, PKA is a tetramer composed of two catalytic and two regulatory subunits (Francis and Corbin, 1999). cAMP, when elevated, binds to the regulatory subunits, resulting in the dissociation of the inactive holoenzyme and the release of